» Articles » PMID: 16205715

Therapeutics Development for Triplet Repeat Expansion Diseases

Overview
Journal Nat Rev Genet
Specialty Genetics
Date 2005 Oct 6
PMID 16205715
Citations 63
Authors
Affiliations
Soon will be listed here.
Abstract

The underlying genetic mutations for many inherited neurodegenerative disorders have been identified in recent years. One frequent type of mutation is trinucleotide repeat expansion. Depending on the location of the repeat expansion, the mutation might result in a loss of function of the disease gene, a toxic gain of function or both. Disease gene identification has led to the development of model systems for investigating disease mechanisms and evaluating treatments. Examination of experimental findings reveals similarities in disease mechanisms as well as possibilities for treatment.

Citing Articles

Base editing strategies to convert CAG to CAA diminish the disease-causing mutation in Huntington's disease.

Choi D, Shin J, Zeng S, Hong E, Jang J, Loupe J Elife. 2024; 12.

PMID: 38869243 PMC: 11175616. DOI: 10.7554/eLife.89782.


Modification of Huntington's disease by short tandem repeats.

Hong E, Ramos E, Aziz N, Massey T, McAllister B, Lobanov S Brain Commun. 2024; 6(2):fcae016.

PMID: 38449714 PMC: 10917446. DOI: 10.1093/braincomms/fcae016.


A plant-based mutant huntingtin model-driven discovery of impaired expression of GTPCH and DHFR.

Hung C, Zhu C, Kittur F, He M, Arning E, Zhang J Cell Mol Life Sci. 2022; 79(11):553.

PMID: 36251090 PMC: 9576654. DOI: 10.1007/s00018-022-04587-6.


Molecular insights into the interaction of CAG trinucleotide RNA repeats with nucleolin and its implication in polyglutamine diseases.

An Y, Chen Z, Chan H, Ngo J Nucleic Acids Res. 2022; 50(13):7655-7668.

PMID: 35776134 PMC: 9303306. DOI: 10.1093/nar/gkac532.


IGF-1 as a Potential Therapy for Spinocerebellar Ataxia Type 3.

Lin Y, Cheng W, Chang J, Lin T, Chao Y, Liu C Biomedicines. 2022; 10(2).

PMID: 35203722 PMC: 8962315. DOI: 10.3390/biomedicines10020505.